News | Mammography Reporting Software | June 13, 2019

Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA

New introductions include automated, closed loop resolution manager with integrated pathology reporting, and web-based breast cancer risk assessment

Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA

June 13, 2019 — Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA) management tools designed to improve reporting efficiency, and optimize facility operations at two upcoming radiology meetings. The company will be exhibiting at the Society for Imaging Informatics in Medicine (SIIM) annual meeting, June 26-28 in Aurora, Colo., and the Association for Medical Imaging Management (AHRA) annual meeting, July 21-25 in Aurora.

Ikonopedia recently introduced an automated, closed loop resolution manager with integrated pathology reporting capabilities to make sure that patient findings do not get lost in the shuffle of a busy clinic.  

To expand access to quality breast healthcare, Ikonopedia also recently introduced an integrated risk assessment tool, now available in any language. The company also provides users with the first-ever web-based version of the Tyrer-Cuzick Breast Cancer Risk Assessment Tool. Risk data is used to create alerts for the radiologist, populate the clinical section of the report and automatically update the patient letter. A high-risk patient alert identifies patients with a 20 percent or greater lifetime risk and information about the score is instantly viewable.

For more information: www.ikonopedia.com

Related Content

 Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions for chest X-ray and mammography at partner booths.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Lunit, a leading medical AI software company, will be joining the 106th...
ProFound AI for DBT offers superior clinical performance when compared to other commercially available breast AI systems
News | Breast Imaging | November 24, 2020
November 24, 2020 — iCAD reported that over 1,000 licenses have been sold as part of...
Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
News | Mammography | November 20, 2020
November 20, 2020 — Densitas Inc., a global provider of A.I.
Radiologists around the world will have access to a first-of-its-kind online breast density training tool designed to improve radiologists' ability to correctly identify women's breast density categories to comply with the Breast Imaging-Reporting and Data System (BI-RADS), thanks to a collaboration between DetectED-X and Volpara Health. 
News | Breast Density | November 19, 2020
November 19, 2020 — Radiologists around the world will have access to a first-of-its-kind online...
Reduces the complexity of reporting for screening and diagnostic MRI eams to deliver time-saving and patient safety benefits
News | MRI Breast | November 18, 2020
November 18, 2020 — ...
An interview with Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, on the effects on breast imaging in the COVID-19 era

Getty Images

Feature | Breast Imaging | November 12, 2020 | By Dave Fornell
The pandemic forced many elective procedures, including most areas of...
Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single

Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single-slice DBT image in craniocaudal view. C, Magnification of the lesion depicted in B. D, Image from SM in mediolateral oblique view. E, Single-slice DBT image in mediolateral oblique view. F, Magnification of the lesion depicted in E. Images courtesy of Radiological Society of North America

News | Breast Imaging | November 11, 2020
November 11, 2020 — ...
Hologic, Inc. announced innovative updates to its Unifi Analytics platform, a breakthrough business intelligence tool that provides mammography centers insights into technologist performance, proactive device maintenance, and business considerations.
News | Mammography | November 10, 2020
November 10, 2020 — Hologic, Inc.